Health, Vaccines, Lyme Disease, FDA, Medicine.
essentially stops expressing those crucial OspA proteins. Hence, for an OspA vaccine to work, the person vaccinated has to produce enough antibodies to block transmission of the bacteria into the host — and that means many booster shots could be necessary (2). Another strike against the vaccine: